Advertisement

Index by author

November 01, 1980; Volume 215,Issue 2

A

  1. Abu-Hamdan, D

    1. Phenytoin, renal function and renin release.
      S D Migdal, G L Slick, D Abu-Hamdan and F D McDonald
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 304-308;

  2. Adolphson, R L

    1. Cyclic nucleotides and contraction/relaxation in airway muscle: H1 and H2 agonists and antagonists.
      P G Duncan, C Brink, R L Adolphson and J S Douglas
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 434-442;

  3. Awad, S A

    1. Response of the bladder to bethanechol after acute spinal cord transection in cats.
      D A Twiddy, J W Downie and S A Awad
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 500-506;

  4. Azzaro, A J

    1. The presence of the type A form of monoamine oxidase within nigrostriatal dopamine-containing neurons.
      K T Demarest, D J Smith and A J Azzaro
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 461-468;

B

  1. Baba, N

    1. Improvement of human myocardial mitochondria after dobutamine: a quantitative ultrastructural study.
      D V Unverferth, C V Leier, R D Magorien, R Croskery, J R Svirbely, A J Kolibash, M R Dick, J A Meacham and N Baba
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 527-532;

  2. Ban, T

    1. Effects of acebutolol and other structurally related beta adrenergic blockers on transmembrane action potential in guinea-pig papillary muscles.
      H Sada and T Ban
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 507-514;

  3. Benet, L Z

    1. Prednisolone clearance at steady state in dogs.
      F J Frey, B M Frey, A Greither and L Z Benet
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 287-291;

  4. Bentley, J B

    1. Disposition of enflurane in obese patients.
      M S Miller, A J Gandolfi, R W Vaughan and J B Bentley
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 292-296;

  5. Bernard, J D

    1. Effects of castration and chronic morphine administration on liver alcohol dehydrogenase and the metabolism of ethanol in the male Sprague-Dawley rat.
      T J Cicero, J D Bernard and K Newman
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 317-324;

  6. Biegon, R L

    1. Muscarinic antagonism of the effects of phosphodiesterase inhibitor (methylisobutylxanthine) in embryonic chick ventricle.
      R L Biegon, P M Epstein and A J Pappano
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 348-356;

  7. Boerth, R C

    1. Regulatory role of glutathione and soluble sulfhydryl groups in the toxicity of adriamycin.
      R D Olson, J S MacDonald, C J vanBoxtel, R C Boerth, R D Harbison, A E Slonim, R W Freeman and J A Oates
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 450-454;

  8. Brezenoff, H E

    1. Modulatory effect of brain acetylcholine on reflex-induced bradycardia and tachycardia in conscious rats.
      A P Caputi, F Rossi, K Carney and H E Brezenoff
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 309-316;

  9. Brink, C

    1. Response and sensitivity of female guinea-pig respiratory tissues to agonists during ontogenesis.
      C Brink, P G Duncan, M Midzenski and J S Douglas
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 426-433;
    2. Cyclic nucleotides and contraction/relaxation in airway muscle: H1 and H2 agonists and antagonists.
      P G Duncan, C Brink, R L Adolphson and J S Douglas
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 434-442;

  10. Brown, W W

    1. Metabolism of benzidine by a prostaglandin-mediated process in renal inner medullary slices.
      N S Rapp, T V Zenser, W W Brown and B B Davis
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 401-406;

  11. Burks, T F

    1. Tolerance to the effects of morphine on intestinal motility of unanesthetized dogs.
      N W Weisbrodt, P J Thor, E M Copeland and T F Burks
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 515-521;

C

  1. Caputi, A P

    1. Modulatory effect of brain acetylcholine on reflex-induced bradycardia and tachycardia in conscious rats.
      A P Caputi, F Rossi, K Carney and H E Brezenoff
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 309-316;

  2. Carney, K

    1. Modulatory effect of brain acetylcholine on reflex-induced bradycardia and tachycardia in conscious rats.
      A P Caputi, F Rossi, K Carney and H E Brezenoff
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 309-316;

  3. Cheng, L

    1. Gentamicin uptake by renal tubule brush border membrane vesicles.
      J J Lipsky, L Cheng, B Sacktor and P S Lietman
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 390-393;

  4. Cicero, T J

    1. Effects of castration and chronic morphine administration on liver alcohol dehydrogenase and the metabolism of ethanol in the male Sprague-Dawley rat.
      T J Cicero, J D Bernard and K Newman
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 317-324;

  5. Cohen, M L

    1. Antagonist dissociation constants and relative agonist efficacies for compounds interacting with beta-1 and beta-2 adrenergic receptors in the rat jugular vein.
      M L Cohen, R R Ruffolo and K S Wiley
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 325-331;

  6. Cohen, R

    1. Differing electrophysiologic effects of slow response inhibiting agents manganese and verapamil on ischemic, infarcted and normal tissue in situ.
      J Kupersmith and R Cohen
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 394-400;

  7. Copeland, E M

    1. Tolerance to the effects of morphine on intestinal motility of unanesthetized dogs.
      N W Weisbrodt, P J Thor, E M Copeland and T F Burks
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 515-521;

  8. Costa, E

    1. Increase of neurotensin content elicited by neuroleptics in nucleus accumbens.
      S Govoni, J S Hong, H Y Yang and E Costa
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 413-417;

  9. Croskery, R

    1. Improvement of human myocardial mitochondria after dobutamine: a quantitative ultrastructural study.
      D V Unverferth, C V Leier, R D Magorien, R Croskery, J R Svirbely, A J Kolibash, M R Dick, J A Meacham and N Baba
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 527-532;

  10. Cubeddu, L X

    1. Presynaptic effects of 2-aminotetralins on striatal dopaminergic neurons.
      I S Hoffmann, R J Naylor and L X Cubeddu
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 486-493;

D

  1. Daniel, A

    1. Does histamine influence vasodilation caused by prolonged arterial occlusion or heavy exercise?
      A Daniel and C R Honig
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 533-538;

  2. Davis, B B

    1. Metabolism of benzidine by a prostaglandin-mediated process in renal inner medullary slices.
      N S Rapp, T V Zenser, W W Brown and B B Davis
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 401-406;

  3. Dedek, J

    1. Antidopaminergic properties of yohimbine.
      B Scatton, B Zivkovic and J Dedek
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 494-499;

  4. Demarest, K T

    1. The presence of the type A form of monoamine oxidase within nigrostriatal dopamine-containing neurons.
      K T Demarest, D J Smith and A J Azzaro
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 461-468;

  5. Deskin, R

    1. Maturation of sympathetic neurotransmission in the rat heart. VI. The effect of neonatal central catecholaminergic lesions.
      R Deskin, E Mills, W L Whitmore, F J Seidler and T A Slotkin
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 342-347;

  6. Dick, M R

    1. Improvement of human myocardial mitochondria after dobutamine: a quantitative ultrastructural study.
      D V Unverferth, C V Leier, R D Magorien, R Croskery, J R Svirbely, A J Kolibash, M R Dick, J A Meacham and N Baba
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 527-532;

  7. Douglas, J S

    1. Response and sensitivity of female guinea-pig respiratory tissues to agonists during ontogenesis.
      C Brink, P G Duncan, M Midzenski and J S Douglas
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 426-433;
    2. Cyclic nucleotides and contraction/relaxation in airway muscle: H1 and H2 agonists and antagonists.
      P G Duncan, C Brink, R L Adolphson and J S Douglas
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 434-442;

  8. Downie, J W

    1. Response of the bladder to bethanechol after acute spinal cord transection in cats.
      D A Twiddy, J W Downie and S A Awad
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 500-506;

  9. Dun, N J

    1. A comparative study of the pharmacological properties of the positive potential recorded from the superior cervical ganglia of several species.
      N J Dun and A G Karczmar
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 455-460;

  10. Duncan, P G

    1. Response and sensitivity of female guinea-pig respiratory tissues to agonists during ontogenesis.
      C Brink, P G Duncan, M Midzenski and J S Douglas
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 426-433;
    2. Cyclic nucleotides and contraction/relaxation in airway muscle: H1 and H2 agonists and antagonists.
      P G Duncan, C Brink, R L Adolphson and J S Douglas
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 434-442;

E

  1. Epstein, P M

    1. Muscarinic antagonism of the effects of phosphodiesterase inhibitor (methylisobutylxanthine) in embryonic chick ventricle.
      R L Biegon, P M Epstein and A J Pappano
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 348-356;

F

  1. Ferrier, G R

    1. Effects of transmembrane potential on oscillatory afterpotentials induced by acetylstrophanthidin in canine ventricular tissues.
      G R Ferrier
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 332-341;

  2. Freeman, R W

    1. Regulatory role of glutathione and soluble sulfhydryl groups in the toxicity of adriamycin.
      R D Olson, J S MacDonald, C J vanBoxtel, R C Boerth, R D Harbison, A E Slonim, R W Freeman and J A Oates
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 450-454;

  3. Fregly, M J

    1. Effect of the angiotensin converting enzyme inhibitor, captopril, on NaCl appetite of rats.
      M J Fregly
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 407-412;

  4. Frey, B M

    1. Prednisolone clearance at steady state in dogs.
      F J Frey, B M Frey, A Greither and L Z Benet
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 287-291;

  5. Frey, F J

    1. Prednisolone clearance at steady state in dogs.
      F J Frey, B M Frey, A Greither and L Z Benet
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 287-291;

G

  1. Gandolfi, A J

    1. Disposition of enflurane in obese patients.
      M S Miller, A J Gandolfi, R W Vaughan and J B Bentley
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 292-296;

  2. Govoni, S

    1. Increase of neurotensin content elicited by neuroleptics in nucleus accumbens.
      S Govoni, J S Hong, H Y Yang and E Costa
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 413-417;

  3. Greeberg, S

    1. Studies on the effect of chronic oral administration of minoxidil and hydralazine on vascular function in spontaneously hypertensive rats.
      S Greeberg
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 279-286;

  4. Greither, A

    1. Prednisolone clearance at steady state in dogs.
      F J Frey, B M Frey, A Greither and L Z Benet
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 287-291;

H

  1. Harbison, R D

    1. Regulatory role of glutathione and soluble sulfhydryl groups in the toxicity of adriamycin.
      R D Olson, J S MacDonald, C J vanBoxtel, R C Boerth, R D Harbison, A E Slonim, R W Freeman and J A Oates
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 450-454;

  2. Hashimoto, K

    1. The ionic mechanism of prolongation of action potential duration of cardiac ventricular muscle by anthopleurin-A and its relationship to the inotropic effect.
      K Hashimoto, R Ochi, K Hashimoto, J Inui and Y Miura
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 479-485;
    2. The ionic mechanism of prolongation of action potential duration of cardiac ventricular muscle by anthopleurin-A and its relationship to the inotropic effect.
      K Hashimoto, R Ochi, K Hashimoto, J Inui and Y Miura
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 479-485;

  3. Henry, D P

    1. Mechanism of renal tubular secretion of norepinephrine in the rabbit.
      R W Lappe, D P Henry and L R Willis
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 443-449;

  4. Hilton, J G

    1. Effects of alpha adrenergic blockade, combined nicotinic and muscarinic ganglion blockade and spinal anesthesia upon norepinephrine depression of ganglion transmission in the dog.
      J G Hilton
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 522-526;

  5. Ho, W K

    1. Possible generation of potent vasocontracting substance from prostaglandin endoperoxide analogs, human platelets mixture.
      S Shibata, W K Ho and U Ishida
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 357-362;

  6. Hoffmann, I S

    1. Presynaptic effects of 2-aminotetralins on striatal dopaminergic neurons.
      I S Hoffmann, R J Naylor and L X Cubeddu
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 486-493;

  7. Holtzman, S G

    1. Stereoselectivity of the stimulus effects of morphine and cyclazocine in the squirrel monkey.
      J J Teal and S G Holtzman
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 369-376;

  8. Hong, J S

    1. Increase of neurotensin content elicited by neuroleptics in nucleus accumbens.
      S Govoni, J S Hong, H Y Yang and E Costa
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 413-417;

  9. Honig, C R

    1. Does histamine influence vasodilation caused by prolonged arterial occlusion or heavy exercise?
      A Daniel and C R Honig
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 533-538;

I

  1. Inui, J

    1. The ionic mechanism of prolongation of action potential duration of cardiac ventricular muscle by anthopleurin-A and its relationship to the inotropic effect.
      K Hashimoto, R Ochi, K Hashimoto, J Inui and Y Miura
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 479-485;

  2. Ishida, U

    1. Possible generation of potent vasocontracting substance from prostaglandin endoperoxide analogs, human platelets mixture.
      S Shibata, W K Ho and U Ishida
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 357-362;

K

  1. Karaki, H

    1. Dissociation of varied actions of norepinephrine on 45Ca uptake and release at different sites in rabbit aortic smooth muscle.
      H Karaki and G B Weiss
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 363-368;

  2. Karczmar, A G

    1. A comparative study of the pharmacological properties of the positive potential recorded from the superior cervical ganglia of several species.
      N J Dun and A G Karczmar
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 455-460;

  3. Khazan, N

    1. Comparative study of the electroencephalographic and behavioral effects of l-alpha-acetylmethadol (LAAM), two of its metabolites and morphine and methadone in the rat.
      S E Lukas, J E Moreton and N Khazan
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 382-389;

  4. Kolibash, A J

    1. Improvement of human myocardial mitochondria after dobutamine: a quantitative ultrastructural study.
      D V Unverferth, C V Leier, R D Magorien, R Croskery, J R Svirbely, A J Kolibash, M R Dick, J A Meacham and N Baba
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 527-532;

  5. Kupersmith, J

    1. Differing electrophysiologic effects of slow response inhibiting agents manganese and verapamil on ischemic, infarcted and normal tissue in situ.
      J Kupersmith and R Cohen
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 394-400;

L

  1. Lalley, P M

    1. Inhibition of depressor cardiovascular reflexes by a derivative of gamma-aminobutyric acid (GABA) and by general anesthetics with suspected GABA-mimetic effects.
      P M Lalley
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 418-425;

  2. Lappe, R W

    1. Mechanism of renal tubular secretion of norepinephrine in the rabbit.
      R W Lappe, D P Henry and L R Willis
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 443-449;

  3. Leier, C V

    1. Improvement of human myocardial mitochondria after dobutamine: a quantitative ultrastructural study.
      D V Unverferth, C V Leier, R D Magorien, R Croskery, J R Svirbely, A J Kolibash, M R Dick, J A Meacham and N Baba
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 527-532;

  4. Lichtenstein, L M

    1. Hydrocortisone and human lymphocytes: increases in cyclic adenosine 3':5'-monophosphate and potentiation of adenylate cyclase-activating agents.
      G Marone, L M Lichtenstein and M Plaut
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 469-478;

  5. Lietman, P S

    1. Gentamicin uptake by renal tubule brush border membrane vesicles.
      J J Lipsky, L Cheng, B Sacktor and P S Lietman
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 390-393;

  6. Lipsky, J J

    1. Gentamicin uptake by renal tubule brush border membrane vesicles.
      J J Lipsky, L Cheng, B Sacktor and P S Lietman
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 390-393;

  7. Lukas, S E

    1. Comparative study of the electroencephalographic and behavioral effects of l-alpha-acetylmethadol (LAAM), two of its metabolites and morphine and methadone in the rat.
      S E Lukas, J E Moreton and N Khazan
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 382-389;

M

  1. MacDonald, J S

    1. Regulatory role of glutathione and soluble sulfhydryl groups in the toxicity of adriamycin.
      R D Olson, J S MacDonald, C J vanBoxtel, R C Boerth, R D Harbison, A E Slonim, R W Freeman and J A Oates
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 450-454;

  2. Magorien, R D

    1. Improvement of human myocardial mitochondria after dobutamine: a quantitative ultrastructural study.
      D V Unverferth, C V Leier, R D Magorien, R Croskery, J R Svirbely, A J Kolibash, M R Dick, J A Meacham and N Baba
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 527-532;

  3. Marone, G

    1. Hydrocortisone and human lymphocytes: increases in cyclic adenosine 3':5'-monophosphate and potentiation of adenylate cyclase-activating agents.
      G Marone, L M Lichtenstein and M Plaut
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 469-478;

  4. McDonald, F D

    1. Phenytoin, renal function and renin release.
      S D Migdal, G L Slick, D Abu-Hamdan and F D McDonald
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 304-308;

  5. Meacham, J A

    1. Improvement of human myocardial mitochondria after dobutamine: a quantitative ultrastructural study.
      D V Unverferth, C V Leier, R D Magorien, R Croskery, J R Svirbely, A J Kolibash, M R Dick, J A Meacham and N Baba
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 527-532;

  6. Midzenski, M

    1. Response and sensitivity of female guinea-pig respiratory tissues to agonists during ontogenesis.
      C Brink, P G Duncan, M Midzenski and J S Douglas
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 426-433;

  7. Migdal, S D

    1. Phenytoin, renal function and renin release.
      S D Migdal, G L Slick, D Abu-Hamdan and F D McDonald
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 304-308;

  8. Miller, M S

    1. Disposition of enflurane in obese patients.
      M S Miller, A J Gandolfi, R W Vaughan and J B Bentley
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 292-296;

  9. Mills, E

    1. Maturation of sympathetic neurotransmission in the rat heart. VI. The effect of neonatal central catecholaminergic lesions.
      R Deskin, E Mills, W L Whitmore, F J Seidler and T A Slotkin
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 342-347;

  10. Miura, Y

    1. The ionic mechanism of prolongation of action potential duration of cardiac ventricular muscle by anthopleurin-A and its relationship to the inotropic effect.
      K Hashimoto, R Ochi, K Hashimoto, J Inui and Y Miura
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 479-485;

  11. Moreton, J E

    1. Comparative study of the electroencephalographic and behavioral effects of l-alpha-acetylmethadol (LAAM), two of its metabolites and morphine and methadone in the rat.
      S E Lukas, J E Moreton and N Khazan
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 382-389;

N

  1. Naylor, R J

    1. Presynaptic effects of 2-aminotetralins on striatal dopaminergic neurons.
      I S Hoffmann, R J Naylor and L X Cubeddu
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 486-493;

  2. Newman, K

    1. Effects of castration and chronic morphine administration on liver alcohol dehydrogenase and the metabolism of ethanol in the male Sprague-Dawley rat.
      T J Cicero, J D Bernard and K Newman
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 317-324;

O

  1. Oates, J A

    1. Regulatory role of glutathione and soluble sulfhydryl groups in the toxicity of adriamycin.
      R D Olson, J S MacDonald, C J vanBoxtel, R C Boerth, R D Harbison, A E Slonim, R W Freeman and J A Oates
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 450-454;

  2. Ochi, R

    1. The ionic mechanism of prolongation of action potential duration of cardiac ventricular muscle by anthopleurin-A and its relationship to the inotropic effect.
      K Hashimoto, R Ochi, K Hashimoto, J Inui and Y Miura
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 479-485;

  3. Olson, R D

    1. Regulatory role of glutathione and soluble sulfhydryl groups in the toxicity of adriamycin.
      R D Olson, J S MacDonald, C J vanBoxtel, R C Boerth, R D Harbison, A E Slonim, R W Freeman and J A Oates
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 450-454;

P

  1. Pappano, A J

    1. Muscarinic antagonism of the effects of phosphodiesterase inhibitor (methylisobutylxanthine) in embryonic chick ventricle.
      R L Biegon, P M Epstein and A J Pappano
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 348-356;

  2. Patterson, B A

    1. The cyclic nucleotide content of the rat superior cervical ganglion.
      L F Quenzer, B A Patterson and R L Volle
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 297-303;

  3. Plaut, M

    1. Hydrocortisone and human lymphocytes: increases in cyclic adenosine 3':5'-monophosphate and potentiation of adenylate cyclase-activating agents.
      G Marone, L M Lichtenstein and M Plaut
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 469-478;

  4. Pruett, J K

    1. Propranolol effects on membrane repolarization time in isolated canine Purkinje fibers: threshold tissue content and the influence of exposure time.
      J K Pruett, T Walle and U K Walle
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 539-543;

Q

  1. Quenzer, L F

    1. The cyclic nucleotide content of the rat superior cervical ganglion.
      L F Quenzer, B A Patterson and R L Volle
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 297-303;

R

  1. Rapp, N S

    1. Metabolism of benzidine by a prostaglandin-mediated process in renal inner medullary slices.
      N S Rapp, T V Zenser, W W Brown and B B Davis
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 401-406;

  2. Rossi, F

    1. Modulatory effect of brain acetylcholine on reflex-induced bradycardia and tachycardia in conscious rats.
      A P Caputi, F Rossi, K Carney and H E Brezenoff
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 309-316;

  3. Ruffolo, R R

    1. Antagonist dissociation constants and relative agonist efficacies for compounds interacting with beta-1 and beta-2 adrenergic receptors in the rat jugular vein.
      M L Cohen, R R Ruffolo and K S Wiley
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 325-331;

S

  1. Sacktor, B

    1. Gentamicin uptake by renal tubule brush border membrane vesicles.
      J J Lipsky, L Cheng, B Sacktor and P S Lietman
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 390-393;

  2. Sada, H

    1. Effects of acebutolol and other structurally related beta adrenergic blockers on transmembrane action potential in guinea-pig papillary muscles.
      H Sada and T Ban
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 507-514;

  3. Scatton, B

    1. Antidopaminergic properties of yohimbine.
      B Scatton, B Zivkovic and J Dedek
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 494-499;

  4. Seidler, F J

    1. Maturation of sympathetic neurotransmission in the rat heart. VI. The effect of neonatal central catecholaminergic lesions.
      R Deskin, E Mills, W L Whitmore, F J Seidler and T A Slotkin
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 342-347;

  5. Shibata, S

    1. Possible generation of potent vasocontracting substance from prostaglandin endoperoxide analogs, human platelets mixture.
      S Shibata, W K Ho and U Ishida
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 357-362;

  6. Slick, G L

    1. Phenytoin, renal function and renin release.
      S D Migdal, G L Slick, D Abu-Hamdan and F D McDonald
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 304-308;

  7. Slonim, A E

    1. Regulatory role of glutathione and soluble sulfhydryl groups in the toxicity of adriamycin.
      R D Olson, J S MacDonald, C J vanBoxtel, R C Boerth, R D Harbison, A E Slonim, R W Freeman and J A Oates
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 450-454;

  8. Slotkin, T A

    1. Maturation of sympathetic neurotransmission in the rat heart. VI. The effect of neonatal central catecholaminergic lesions.
      R Deskin, E Mills, W L Whitmore, F J Seidler and T A Slotkin
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 342-347;

  9. Smith, D J

    1. The presence of the type A form of monoamine oxidase within nigrostriatal dopamine-containing neurons.
      K T Demarest, D J Smith and A J Azzaro
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 461-468;

  10. Su, C

    1. Potentiative effects of alpha agonistic sympathomimetic amines on vasoconstriction by adrenergic nerve stimulation.
      C Su
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 377-381;

  11. Svirbely, J R

    1. Improvement of human myocardial mitochondria after dobutamine: a quantitative ultrastructural study.
      D V Unverferth, C V Leier, R D Magorien, R Croskery, J R Svirbely, A J Kolibash, M R Dick, J A Meacham and N Baba
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 527-532;

T

  1. Teal, J J

    1. Stereoselectivity of the stimulus effects of morphine and cyclazocine in the squirrel monkey.
      J J Teal and S G Holtzman
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 369-376;

  2. Thor, P J

    1. Tolerance to the effects of morphine on intestinal motility of unanesthetized dogs.
      N W Weisbrodt, P J Thor, E M Copeland and T F Burks
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 515-521;

  3. Twiddy, D A

    1. Response of the bladder to bethanechol after acute spinal cord transection in cats.
      D A Twiddy, J W Downie and S A Awad
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 500-506;

U

  1. Unverferth, D V

    1. Improvement of human myocardial mitochondria after dobutamine: a quantitative ultrastructural study.
      D V Unverferth, C V Leier, R D Magorien, R Croskery, J R Svirbely, A J Kolibash, M R Dick, J A Meacham and N Baba
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 527-532;

V

  1. vanBoxtel, C J

    1. Regulatory role of glutathione and soluble sulfhydryl groups in the toxicity of adriamycin.
      R D Olson, J S MacDonald, C J vanBoxtel, R C Boerth, R D Harbison, A E Slonim, R W Freeman and J A Oates
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 450-454;

  2. Vaughan, R W

    1. Disposition of enflurane in obese patients.
      M S Miller, A J Gandolfi, R W Vaughan and J B Bentley
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 292-296;

  3. Volle, R L

    1. The cyclic nucleotide content of the rat superior cervical ganglion.
      L F Quenzer, B A Patterson and R L Volle
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 297-303;

W

  1. Walle, T

    1. Propranolol effects on membrane repolarization time in isolated canine Purkinje fibers: threshold tissue content and the influence of exposure time.
      J K Pruett, T Walle and U K Walle
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 539-543;

  2. Walle, U K

    1. Propranolol effects on membrane repolarization time in isolated canine Purkinje fibers: threshold tissue content and the influence of exposure time.
      J K Pruett, T Walle and U K Walle
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 539-543;

  3. Weisbrodt, N W

    1. Tolerance to the effects of morphine on intestinal motility of unanesthetized dogs.
      N W Weisbrodt, P J Thor, E M Copeland and T F Burks
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 515-521;

  4. Weiss, G B

    1. Dissociation of varied actions of norepinephrine on 45Ca uptake and release at different sites in rabbit aortic smooth muscle.
      H Karaki and G B Weiss
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 363-368;

  5. Whitmore, W L

    1. Maturation of sympathetic neurotransmission in the rat heart. VI. The effect of neonatal central catecholaminergic lesions.
      R Deskin, E Mills, W L Whitmore, F J Seidler and T A Slotkin
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 342-347;

  6. Wiley, K S

    1. Antagonist dissociation constants and relative agonist efficacies for compounds interacting with beta-1 and beta-2 adrenergic receptors in the rat jugular vein.
      M L Cohen, R R Ruffolo and K S Wiley
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 325-331;

  7. Willis, L R

    1. Mechanism of renal tubular secretion of norepinephrine in the rabbit.
      R W Lappe, D P Henry and L R Willis
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 443-449;

Y

  1. Yang, H Y

    1. Increase of neurotensin content elicited by neuroleptics in nucleus accumbens.
      S Govoni, J S Hong, H Y Yang and E Costa
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 413-417;

Z

  1. Zenser, T V

    1. Metabolism of benzidine by a prostaglandin-mediated process in renal inner medullary slices.
      N S Rapp, T V Zenser, W W Brown and B B Davis
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 401-406;

  2. Zivkovic, B

    1. Antidopaminergic properties of yohimbine.
      B Scatton, B Zivkovic and J Dedek
      Journal of Pharmacology and Experimental Therapeutics November 1980, 215 (2) 494-499;
Back to top

In this issue